Legend Stock Performance

Stocks . USA . 
Stock . Legend BiotechCorp
LEGN Stock  USD 48.00  0.14  0.29%   
The company secures a Beta (Market Risk) of 1.4127, which conveys a somewhat significant risk relative to the market. Let's try to break down what Legend's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Legend BiotechCorp will likely underperform. Even though it is essential to pay attention to Legend BiotechCorp price patterns, it is always good to be careful when utilizing equity historical price patterns. Our philosophy towards estimating any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Legend BiotechCorp exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Legend BiotechCorp has an expected return of -0.0247%. Please be advised to verify Legend BiotechCorp jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution to decide if Legend BiotechCorp performance from the past will be repeated at some point in the near future.
  

Legend Performance

0 of 100

Over the last 90 days Legend BiotechCorp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, Legend BiotechCorp is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the insiders. ...more
1
Other01/03/2023
2
What is February outlook for Legend BiotechCorp01/10/2023
3
Camila Mendes details struggles with eating disorder I was r...01/26/2023
4
Legend Biotech Announces Phase 3 CARTITUDE-4 Study of CARVYK...01/27/2023
5
Should You Add Legend Biotech Corp Stock to Your Portfolio M...01/30/2023
6
Genscript Bio Gets Booster From Subsidiarys New Cancer Drug ...02/02/2023
7
Biotech stocks that could surge more than 35 percent include...02/09/2023
8
Unclassified Event02/14/2023
9
Legend Biotech Regains Compliance with NASDAQ Listing Rule 5...02/21/2023
10
Is Legend Biotech Corp Stock at the Top of the Biotechnology...02/22/2023
11
RSI Alert Legend Biotech Now Oversold - Nasdaq03/10/2023
12
Legend Biotech Coverage Initiated by Analysts at HC Wainwrig...03/29/2023
Begin Period Cash Flow455.7 M
Total Cashflows From Investing Activities-195 M

Legend BiotechCorp Relative Risk vs. Return Landscape

If you would invest  4,992  in Legend BiotechCorp on December 30, 2022 and sell it today you would lose (192.00)  from holding Legend BiotechCorp or give up 3.85% of portfolio value over 90 days. Legend BiotechCorp is currently does not generate positive expected returns and assumes 2.8054% risk (volatility on return distribution) over the 90 days horizon. In different words, 24% of stocks are less volatile than Legend, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Daily Expected Return (%)  
       Risk (%)  
Given the investment horizon of 90 days Legend BiotechCorp is expected to under-perform the market. In addition to that, the company is 2.97 times more volatile than its market benchmark. It trades about -0.01 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.01 per unit of volatility.

Legend BiotechCorp Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Legend BiotechCorp's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Legend BiotechCorp, and traders can use it to determine the average amount a Legend BiotechCorp's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.0088

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsLEGN

Estimated Market Risk

 2.81
  actual daily
 24 
76% of assets are more volatile
2424

Expected Return

 -0.02
  actual daily
 0 
Most of other assets have higher returns
00

Risk-Adjusted Return

 -0.01
  actual daily
 0 
Most of other assets perform better
00
Based on monthly moving average Legend BiotechCorp is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Legend BiotechCorp by adding it to a well-diversified portfolio.

Legend BiotechCorp Fundamentals Growth

Legend Stock prices reflect investors' perceptions of the future prospects and financial health of Legend BiotechCorp, and Legend BiotechCorp fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Legend Stock performance.
Return On Equity(0.97) %
Return On Asset(0.26) %
Current Valuation8.02 B
Shares Outstanding167.4 M
Price to Book19.80 X
Price to Sales73.18 X
Revenue89.79 M
Gross Profit91.56 M
EBITDA(385.31 M)
Net Income(386.21 M)
Cash and Equivalents791.26 M
Cash per Share5.11 X
Total Debt120.46 M
Debt to Equity0.29 %
Current Ratio3.83 X
Book Value Per Share3.63 X
Cash Flow from Operations(198.47 M)
Earnings Per Share(3.14) X
Market Capitalization7.9 B
Total Asset1.12 B

About Legend BiotechCorp Performance

To evaluate Legend BiotechCorp Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Legend BiotechCorp generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Legend Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Legend BiotechCorp market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Legend's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2023
Effect of Exchange Rate Changes on Cash39.1 K40.1 K
Return on Average Assets(0.42) (0.46) 
Return on Average Equity(1.17) (1.26) 
Return on Invested Capital(11.51) (12.42) 
Return on Sales(5.31) (5.45) 

Things to note about Legend BiotechCorp performance evaluation

Checking the ongoing alerts about Legend BiotechCorp for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Legend BiotechCorp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Legend BiotechCorp generated a negative expected return over the last 90 days
The company reported the previous year's revenue of 89.79 M. Net Loss for the year was (386.21 M) with profit before overhead, payroll, taxes, and interest of 91.56 M.
Legend BiotechCorp currently holds about 791.26 M in cash with (198.47 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Legend BiotechCorp has a frail financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Legend Biotech Coverage Initiated by Analysts at HC Wainwright
Evaluating Legend BiotechCorp's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Legend BiotechCorp's stock performance include:
  • Analyzing Legend BiotechCorp's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Legend BiotechCorp's stock is overvalued or undervalued compared to its peers.
  • Examining Legend BiotechCorp's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Legend BiotechCorp's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Legend BiotechCorp's management team can help you assess the company's leadership.
  • Pay attention to analyst opinions and ratings of Legend BiotechCorp's stock. These opinions can provide insight into Legend BiotechCorp's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Legend BiotechCorp's stock performance is not an exact science, and many factors can impact Legend BiotechCorp's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
Check out Correlation Analysis. To learn how to invest in Legend Stock please use our How to Invest in Legend BiotechCorp guide. Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Legend Stock analysis

When running Legend BiotechCorp price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.14) 
Revenue Per Share
0.788
Quarterly Revenue Growth
(0.42) 
Return On Assets
(0.26) 
Return On Equity
(0.97) 
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine Legend BiotechCorp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2023 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY